A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood

NCT04445090 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

68

Enrollment

INDUSTRY

Sponsor class

Stopped Identification of potential mutagenic metabolite in human plasma

Conditions

Healthy

Interventions

DRUG: BI 1569912
DRUG: Placebo

Sponsor

Boehringer Ingelheim